435 related articles for article (PubMed ID: 24039404)
81. Dissolving polymer microneedle patches for rapid and efficient transdermal delivery of insulin to diabetic rats.
Ling MH; Chen MC
Acta Biomater; 2013 Nov; 9(11):8952-61. PubMed ID: 23816646
[TBL] [Abstract][Full Text] [Related]
82. Rizatriptan benzoate-loaded dissolving microneedle patch for management of acute migraine therapy.
Zhong C; Zhang X; Sun Y; Shen Z; Mao Y; Liu T; Wang R; Nie L; Shavandi A; Yunusov KE; Jiang G
J Biomater Appl; 2024 Apr; 38(9):989-999. PubMed ID: 38427917
[TBL] [Abstract][Full Text] [Related]
83. Microscale engineering of hollow microneedle tips: design, manufacturing, optimization and validation.
Badnikar K; Jayadevi SN; Pahal S; Vemula PK; Nayak MM; Subramanyam DN
Drug Deliv Transl Res; 2022 Feb; 12(2):350-367. PubMed ID: 34664227
[TBL] [Abstract][Full Text] [Related]
84. Panorama of dissolving microneedles for transdermal drug delivery.
Dalvi M; Kharat P; Thakor P; Bhavana V; Singh SB; Mehra NK
Life Sci; 2021 Nov; 284():119877. PubMed ID: 34384832
[TBL] [Abstract][Full Text] [Related]
85. Production of dissolvable microneedles using an atomised spray process: effect of microneedle composition on skin penetration.
McGrath MG; Vucen S; Vrdoljak A; Kelly A; O'Mahony C; Crean AM; Moore A
Eur J Pharm Biopharm; 2014 Feb; 86(2):200-11. PubMed ID: 23727511
[TBL] [Abstract][Full Text] [Related]
86. Fabrication of biodegradable composite microneedles based on calcium sulfate and gelatin for transdermal delivery of insulin.
Yu W; Jiang G; Liu D; Li L; Chen H; Liu Y; Huang Q; Tong Z; Yao J; Kong X
Mater Sci Eng C Mater Biol Appl; 2017 Feb; 71():725-734. PubMed ID: 27987766
[TBL] [Abstract][Full Text] [Related]
87. [Microneedle-based percutaneous immunity: a review].
Li Y; Wang J; Jin Z; Wan W; Bai X; Hu C; Li Y; Xin W; Kang L; Yang H; Wang J; Gao S
Sheng Wu Gong Cheng Xue Bao; 2022 Sep; 38(9):3301-3315. PubMed ID: 36151801
[TBL] [Abstract][Full Text] [Related]
88. Dissolving microneedles for transdermal drug administration prepared by stepwise controlled drawing of maltose.
Lee K; Lee CY; Jung H
Biomaterials; 2011 Apr; 32(11):3134-40. PubMed ID: 21292317
[TBL] [Abstract][Full Text] [Related]
89. Pullulan-based dissolving microneedle arrays for enhanced transdermal delivery of small and large biomolecules.
Vora LK; Courtenay AJ; Tekko IA; Larrañeta E; Donnelly RF
Int J Biol Macromol; 2020 Mar; 146():290-298. PubMed ID: 31883883
[TBL] [Abstract][Full Text] [Related]
90. A novel scalable fabrication process for the production of dissolving microneedle arrays.
Chen H; Wu B; Zhang M; Yang P; Yang B; Qin W; Wang Q; Wen X; Chen M; Quan G; Pan X; Wu C
Drug Deliv Transl Res; 2019 Feb; 9(1):240-248. PubMed ID: 30341765
[TBL] [Abstract][Full Text] [Related]
91. Tapered conical polymer microneedles fabricated using an integrated lens technique for transdermal drug delivery.
Park JH; Yoon YK; Choi SO; Prausnitz MR; Allen MG
IEEE Trans Biomed Eng; 2007 May; 54(5):903-13. PubMed ID: 17518288
[TBL] [Abstract][Full Text] [Related]
92. [Preparation and transdermal effect of a tip-loaded bubble-soluble microneedle].
Zhu L; Zhuang J; Zhao Z; Huang Y; Sun J; Liu F; Xue Q; Wu D
Sheng Wu Gong Cheng Xue Bao; 2022 Jun; 38(6):2281-2291. PubMed ID: 35786479
[TBL] [Abstract][Full Text] [Related]
93. Microneedles: a valuable physical enhancer to increase transdermal drug delivery.
Escobar-Chávez JJ; Bonilla-Martínez D; Villegas-González MA; Molina-Trinidad E; Casas-Alancaster N; Revilla-Vázquez AL
J Clin Pharmacol; 2011 Jul; 51(7):964-77. PubMed ID: 21148047
[TBL] [Abstract][Full Text] [Related]
94. Development of a novel self-dissolving microneedle array of alendronate, a nitrogen-containing bisphosphonate: evaluation of transdermal absorption, safety, and pharmacological effects after application in rats.
Katsumi H; Liu S; Tanaka Y; Hitomi K; Hayashi R; Hirai Y; Kusamori K; Quan YS; Kamiyama F; Sakane T; Yamamoto A
J Pharm Sci; 2012 Sep; 101(9):3230-8. PubMed ID: 22467424
[TBL] [Abstract][Full Text] [Related]
95. Intracorneal injection of a detachable hybrid microneedle for sustained drug delivery.
Lee K; Song HB; Cho W; Kim JH; Kim JH; Ryu W
Acta Biomater; 2018 Oct; 80():48-57. PubMed ID: 30267886
[TBL] [Abstract][Full Text] [Related]
96. Formulation Approach that Enables the Coating of a Stable Influenza Vaccine on a Transdermal Microneedle Patch.
Ameri M; Ao Y; Lewis H
AAPS PharmSciTech; 2021 Jun; 22(5):175. PubMed ID: 34114100
[TBL] [Abstract][Full Text] [Related]
97. Dissolving microneedles for transdermal delivery of huperzine A for the treatment of Alzheimer's disease.
Yan Q; Wang W; Weng J; Zhang Z; Yin L; Yang Q; Guo F; Wang X; Chen F; Yang G
Drug Deliv; 2020 Dec; 27(1):1147-1155. PubMed ID: 32729341
[TBL] [Abstract][Full Text] [Related]
98. Novel dissolving microneedles for enhanced transdermal delivery of levonorgestrel: In vitro and in vivo characterization.
Yao G; Quan G; Lin S; Peng T; Wang Q; Ran H; Chen H; Zhang Q; Wang L; Pan X; Wu C
Int J Pharm; 2017 Dec; 534(1-2):378-386. PubMed ID: 29051119
[TBL] [Abstract][Full Text] [Related]
99. Nanomaterial and advanced technologies in transdermal drug delivery.
Rabiei M; Kashanian S; Samavati SS; Jamasb S; McInnes SJP
J Drug Target; 2020 Apr; 28(4):356-367. PubMed ID: 31851847
[TBL] [Abstract][Full Text] [Related]
100. Hyaluronic acid based microneedle array: Recent applications in drug delivery and cosmetology.
Saha I; Rai VK
Carbohydr Polym; 2021 Sep; 267():118168. PubMed ID: 34119141
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
